Measuring Success in a Complex Therapeutic Landscape Success today goes beyond new prescriptions
Unlike Ozempic (which is a GLP-1 receptor agonist), Zepbound targets both GLP-1 and GIP receptors
The VA said it will enroll more than 600 veterans in the study, which will evaluate semaglutide, a GLP-1 receptor agonist widely used to treat Type 2 diabetes and obesity
doi: 10.2147/ijn.s273713 Summary Keywords immunosuppression, immunotherapy resistance, nanomedicine delivery systems, osteosarcoma, translational oncology, tumor microenvironment (TME) Citation Huang Q, Yu G, Shi B and Deng T (2026) Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion
They can provide personalized guidance based on your specific health needs and conditions
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas